| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.AMJMED.2005.11.034 |
| P698 | PubMed publication ID | 16887417 |
| P50 | author | Piercarlo Sarzi-Puttini | Q30002194 |
| Andrea Doria | Q38544117 | ||
| P2093 | author name string | Fabiola Atzeni | |
| Sandra Zampieri | |||
| Anna Ghirardello | |||
| Luca Iaccarino | |||
| Antonio Piccoli | |||
| Silvano Todesco | |||
| Silvia Arienti | |||
| P433 | issue | 8 | |
| P921 | main subject | systemic lupus erythematosus | Q1485 |
| P304 | page(s) | 700-706 | |
| P577 | publication date | 2006-08-01 | |
| P1433 | published in | American Journal of Medicine | Q2842959 |
| P1476 | title | Long-term prognosis and causes of death in systemic lupus erythematosus | |
| P478 | volume | 119 |
| Q48128911 | An era of biological treatment in systemic lupus erythematosus. |
| Q55401570 | Analysis of Serum Interleukin (IL)-1β and IL-18 in Systemic Lupus Erythematosus. |
| Q36853705 | Anti-inflammatory activities of Ganoderma lucidum (Lingzhi) and San-Miao-San supplements in MRL/lpr mice for the treatment of systemic lupus erythematosus. |
| Q48182257 | Antiphospholipid antibodies, steroid dose, arterial hypertension, relapses, and late-onset predict organ damage in a population of Colombian patients with systemic lupus erythematosus. |
| Q90440414 | Assessment of a high-avidity IgG ANAs for the diagnosis and activity prediction of systemic lupus erythematosus |
| Q34064253 | Association of NCF2, IKZF1, IRF8, IFIH1, and TYK2 with systemic lupus erythematosus |
| Q37319989 | Atherosclerosis in autoimmune rheumatic diseases-mechanisms and clinical findings |
| Q33632260 | Autologous hematopoietic stem cell transplantation for autoimmune diseases: an observational study on 12 years' experience from the European Group for Blood and Marrow Transplantation Working Party on Autoimmune Diseases. |
| Q48004729 | Autologous tolerogenic dendritic cells derived from monocytes of systemic lupus erythematosus patients and healthy donors show a stable and immunosuppressive phenotype. |
| Q36835851 | Cardiovascular co-morbidity in rheumatic diseases |
| Q37330468 | Cardiovascular disease in latin american patients with systemic lupus erythematosus: a cross-sectional study and a systematic review. |
| Q82085325 | Cardiovascular injury in systemic autoimmune diseases: an update |
| Q58847539 | Causes and predictors of death in Brazilian lupus patients |
| Q47164898 | Childhood lupus nephritis: 12 years of experience from a developing country's perspective |
| Q39067278 | Childhood versus adult-onset systemic lupus erythematosus: long-term outcome and predictors of mortality. |
| Q36869519 | Chinese Herbal Medicine (Zi Shen Qing) for Mild-to-Moderate Systematic Lupus Erythematosus: A Pilot Prospective, Single-Blinded, Randomized Controlled Study |
| Q61809081 | Circulating Pentraxin3-Specific B Cells Are Decreased in Lupus Nephritis |
| Q36416287 | Comparison of breast cancer risk in women with and without systemic lupus erythematosus in a Medicare population. |
| Q36083938 | Cross-species transcriptional network analysis defines shared inflammatory responses in murine and human lupus nephritis |
| Q37582300 | Current state and future directions of autologous hematopoietic stem cell transplantation in systemic lupus erythematosus |
| Q38138918 | Death causes and pathogens analysis of systemic lupus erythematosus during the past 26 years |
| Q48243057 | Death-related factors of systemic lupus erythematosus patients associated with the course of disease in Chinese populations: multicenter and retrospective study of 1,958 inpatients |
| Q38763655 | Delays to care in pediatric lupus patients from the Childhood Arthritis and Rheumatology Research Alliance Legacy Registry |
| Q54263409 | Disease characteristics and causes of early and late death in a group of Croatian patients with systemic lupus erythematosus deceased over a 10-year period. |
| Q87984753 | Effectiveness, Tolerability, and Safety of Belimumab in Patients with Refractory SLE: a Review of Observational Clinical-Practice-Based Studies |
| Q36338516 | HDAC expression and activity is upregulated in diseased lupus-prone mice |
| Q37188496 | Haematopoietic SCT in autoimmune diseases in children: rationale and new perspectives |
| Q36020897 | Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation |
| Q34114253 | Health technology assessment of belimumab: a new monoclonal antibody for the treatment of systemic lupus erythematosus |
| Q38922223 | Heart involvement in systemic lupus erythematosus: a systemic review and meta-analysis |
| Q85849984 | Heterogeneity of peripheral blood monocytes, endothelial dysfunction and subclinical atherosclerosis in patients with systemic lupus erythematosus |
| Q45841999 | Human papillomavirus vaccine and systemic lupus erythematosus |
| Q37512540 | Immunosuppressive Treatment for Lupus Nephritis: Long-Term Results in 178 Patients. |
| Q44725614 | Incidence of cancer among female patients with systemic lupus erythematosus in Korea |
| Q26825971 | Infections and Systemic Lupus Erythematosus: Binding or Sparring Partners? |
| Q42220143 | Infections and systemic lupus erythematosus |
| Q26849746 | Juvenile systemic lupus erythematosus: review of clinical features and management |
| Q37072381 | Mechanisms of disease: macrophage migration inhibitory factor in SLE, RA and atherosclerosis |
| Q37684625 | Mortality and cardiovascular burden of systemic lupus erythematosus in a US population-based cohort |
| Q38777770 | Mortality in Systemic Lupus Erythematosus: an Updated Review. |
| Q57491423 | Neuropsychiatric Systemic Lupus Erythematosus Is Dependent on Sphingosine-1-Phosphate Signaling |
| Q90412368 | New therapeutic strategies in systemic lupus erythematosus management |
| Q50052184 | Novel Insights in Systemic Lupus Erythematosus and Atherosclerosis. |
| Q38225438 | Optimizing pharmacotherapy of systemic lupus erythematosus: the pharmacist role |
| Q56942132 | PTX3, Anti-PTX3, and Anti-C1q Autoantibodies in Lupus Glomerulonephritis |
| Q42946041 | Panax notoginseng Saponins Attenuate Atherogenesis Accelerated by Zymosan in Rabbits |
| Q93065552 | Patient perceptions and preferences of biologic therapies in SLE |
| Q33723511 | Pediatric lupus--are there differences in presentation, genetics, response to therapy, and damage accrual compared with adult lupus? |
| Q36318533 | Prediction of chronic damage in systemic lupus erythematosus by using machine-learning models |
| Q47818914 | Predictors of maternal and fetal complications in SLE patients: a prospective study |
| Q81944141 | Primary prevention of systemic lupus erythematosus |
| Q64983842 | Prognostic Factors for Clinical Response in Systemic Lupus Erythematosus Patients Treated by Allogeneic Mesenchymal Stem Cells. |
| Q35309510 | Protective molecules and their cognate antibodies: new players in autoimmunity |
| Q93271975 | Real-world treatment patterns, healthcare resource utilisation and costs in patients with systemic lupus erythematosus treated with belimumab: a retrospective analysis of claims data in the USA |
| Q34654954 | Renal involvement in autoimmune connective tissue diseases |
| Q33766242 | Risk factors for cardiovascular mortality in patients with systemic lupus erythematosus, a prospective cohort study |
| Q41585006 | Spectrum of infections and outcome among hospitalized South Africans with systemic lupus erythematosus |
| Q38287103 | Stem cell autograft and allograft in autoimmune diseases |
| Q36968832 | Subclinical atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus |
| Q22299249 | Survival in systemic lupus erythematosus, 1995-2010. A prospective study in a Danish community |
| Q50848358 | Systemic lupus erythematosus. |
| Q90159347 | Temporal Hemodynamic Changes in a Female Mouse Model of Systemic Lupus Erythematosus |
| Q92816495 | The Impact of Cytokines on the Health-Related Quality of Life in Patients with Systemic Lupus Erythematosus |
| Q45092952 | The early cardiovascular changes in pediatric patients with systemic lupus erythematosus |
| Q37627356 | The use of rituximab in newly diagnosed patients with systemic lupus erythematosus: long-term steroid saving capacity and clinical effectiveness |
| Q46217174 | Total hip arthroplasty for vascular necrosis of the femoral head in patients with systemic lupus erythematosus: a midterm follow-up study of 28 hips in 24 patients |
| Q84815168 | [Changes in mortality and morbidity in systemic lupus erythematosus] |
| Q51957070 | [Immunoablation followed by autologous stem cell transplantation in lupus: a clinical update]. |
Search more.